<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Gibbons RD</submitter><funding>NIMH NIH HHS</funding><pagination>1376-1382</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11986876</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>78(9)</volume><pubmed_abstract>&lt;h4>Objective&lt;/h4>Current suicide risk screening and measurement are inefficient, have limited measurement precision, and focus entirely on suicide-related items. For this study, a psychometric harmonization between related suicide, depression, and anxiety symptom domains that provides a more balanced and complete spectrum of suicidal symptomatology was developed. The objective of this article is to describe the results of the early stages of computerized adaptive testing development for a suicide scale and pave the way for the final stage of validation.&lt;h4>Methods&lt;/h4>Data from psychiatric outpatients at the University of Pittsburgh and a community health clinic were collected from January 2010 through June 2012. 789 participants were enrolled in the calibration phase; 70% were female, an</pubmed_abstract><journal>The Journal of clinical psychiatry</journal><pubmed_title>Development of a Computerized Adaptive Test Suicide Scale-The CAT-SS.</pubmed_title><pmcid>PMC11986876</pmcid><funding_grant_id>R01 MH066302</funding_grant_id><pubmed_authors>Frank E</pubmed_authors><pubmed_authors>Boudreaux ED</pubmed_authors><pubmed_authors>Gibbons RD</pubmed_authors><pubmed_authors>Beiser DG</pubmed_authors><pubmed_authors>Kupfer D</pubmed_authors><pubmed_authors>Moore T</pubmed_authors></additional><is_claimable>false</is_claimable><name>Development of a Computerized Adaptive Test Suicide Scale-The CAT-SS.</name><description>&lt;h4>Objective&lt;/h4>Current suicide risk screening and measurement are inefficient, have limited measurement precision, and focus entirely on suicide-related items. For this study, a psychometric harmonization between related suicide, depression, and anxiety symptom domains that provides a more balanced and complete spectrum of suicidal symptomatology was developed. The objective of this article is to describe the results of the early stages of computerized adaptive testing development for a suicide scale and pave the way for the final stage of validation.&lt;h4>Methods&lt;/h4>Data from psychiatric outpatients at the University of Pittsburgh and a community health clinic were collected from January 2010 through June 2012. 789 participants were enrolled in the calibration phase; 70% were female, an</description><dates><release>2017-01-01T00:00:00Z</release><publication>2017 Nov/Dec</publication><modification>2025-07-13T03:05:11.013Z</modification><creation>2025-07-13T03:05:11.013Z</creation></dates><accession>S-EPMC11986876</accession><cross_references><pubmed>28493655</pubmed><doi>10.4088/jcp.16m10922</doi><doi>10.4088/JCP.16m10922</doi></cross_references></HashMap>